Hospital
Cherokee Medical Center
Cherokee Medical Center was paid $15.38M by Medicaid between Jan 2019 and Dec 2024, across 196 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 17% of everything it billed.
33Billing provider infoCHEROKEE MEDICAL CENTER
GAFFNEY, SC 29340
GAFFNEY, SC 29340
33aNPI1205307378assigned 12/16/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.38M
24GClaims405,789
24DCodes billed196
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#22 of 115
Median peer was paid$2.47M
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MEINKE, KENNETH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 63,016 | $2.33M | |
| 2020 | 53,622 | $1.91M | |
| 2021 | 67,693 | $2.21M | |
| 2022 | 79,656 | $1.99M | |
| 2023 | 76,076 | $3.23M | |
| 2024incomplete | 65,726 | $3.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 17% | 27,098 | 22,924 | $2.64M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 32,777 | 29,022 | $1.83M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9.5% | 4,901 | 4,531 | $1.46M |
| J7030 | Infusion, normal saline solution , 1000 cc | 8.7% | 8,230 | 6,708 | $1.34M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 8.1% | 8,283 | 7,629 | $1.24M |
| 81001 | 5.3% | 18,246 | 16,080 | $817K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4.2% | 1,745 | 1,550 | $650K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 3,305 | 3,093 | $498K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 4,864 | 4,644 | $438K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.1% | 4,144 | 3,365 | $328K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 3,307 | 3,029 | $218K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 4,503 | 4,074 | $189K |
184 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 4,528 | $172K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 4,491 | $172K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 2,061 | $169K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 4,121 | $164K |
| 87081 | <1% | 1,458 | $151K | |
| 73610 | <1% | 1,126 | $146K | |
| 81025 | <1% | 8,272 | $146K | |
| 73630 | <1% | 1,436 | $142K | |
| 71045 | Radiologic examination, chest; single view | <1% | 8,991 | $139K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,037 | $132K |
| 87070 | <1% | 734 | $121K | |
| 76830 | Ultrasound, transvaginal | <1% | 828 | $114K |
| 73130 | <1% | 754 | $111K | |
| 87075 | <1% | 1,190 | $109K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,670 | $108K |
| 81003 | <1% | 1,363 | $96K | |
| 73562 | <1% | 1,213 | $94K | |
| 99284 | Emergency room visit (serious) | <1% | 11,023 | $86K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 869 | $85K |
| 73030 | <1% | 903 | $85K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 694 | $69K |
| 72100 | <1% | 1,270 | $64K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,635 | $62K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,962 | $62K |
| 73110 | <1% | 429 | $56K | |
| 82947 | <1% | 357 | $42K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 28,215 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,567 | $35K |
| 84484 | <1% | 8,677 | $35K | |
| 86780 | <1% | 814 | $33K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,786 | $33K |
| 81015 | <1% | 442 | $32K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,109 | $32K |
| 84702 | <1% | 1,601 | $28K | |
| 74018 | <1% | 688 | $27K | |
| 86756 | <1% | 171 | $27K | |
| 93971 | <1% | 152 | $25K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 954 | $25K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 409 | $24K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,708 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,701 | $21K |
| 87077 | <1% | 1,949 | $19K | |
| 83655 | <1% | 1,027 | $17K | |
| 99285 | Emergency room visit (most serious) | <1% | 5,185 | $15K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 77 | $15K |
| 83690 | <1% | 9,559 | $14K | |
| 83880 | <1% | 3,572 | $14K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,428 | $12K |
| 87807 | <1% | 391 | $12K | |
| C1780 | Lens, intraocular (new technology) | <1% | 99 | $12K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 976 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 447 | $12K |
| 80061 | Lipid panel | <1% | 3,218 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,581 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 95 | $10K |
| 87430 | <1% | 566 | $10K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 3,093 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 851 | $9K |
| 85379 | <1% | 1,139 | $9K | |
| 85027 | <1% | 3,066 | $8K | |
| 87040 | <1% | 2,361 | $8K | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 14 | $8K |
| 87428 | <1% | 127 | $7K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 168 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,864 | $7K |
| 73502 | <1% | 254 | $6K | |
| 82728 | <1% | 451 | $5K | |
| 73090 | <1% | 28 | $5K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,085 | $5K |
| 87150 | <1% | 208 | $5K | |
| 84703 | <1% | 965 | $4K | |
| 87210 | <1% | 765 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 85 | $4K |
| 86850 | <1% | 826 | $4K | |
| 72050 | <1% | 61 | $4K | |
| 84439 | <1% | 637 | $4K | |
| 82950 | <1% | 176 | $4K | |
| 86738 | <1% | 47 | $3K | |
| 86803 | <1% | 922 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,770 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,056 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,262 | $3K |
| 73590 | <1% | 32 | $3K | |
| 12001 | <1% | 12 | $3K | |
| 93017 | <1% | 42 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 845 | $2K |
| 83605 | <1% | 2,537 | $2K | |
| 74022 | <1% | 233 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,598 | $2K |
| 85610 | <1% | 2,592 | $2K | |
| 74019 | <1% | 71 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 1,352 | $2K |
| 86704 | <1% | 62 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,996 | $2K |
| 82570 | <1% | 184 | $2K | |
| 93970 | <1% | 16 | $2K | |
| 73564 | <1% | 25 | $2K | |
| 86900 | <1% | 1,300 | $1K | |
| 73140 | <1% | 15 | $1K | |
| 84436 | <1% | 728 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 15 | $1K |
| 86140 | <1% | 1,425 | $1K | |
| 82077 | <1% | 1,752 | $1K | |
| 82607 | <1% | 317 | $1K | |
| 72070 | <1% | 13 | $1K | |
| 73080 | <1% | 24 | $1K | |
| 82803 | <1% | 457 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,593 | $1K |
| 76801 | <1% | 76 | $1K | |
| 85007 | <1% | 189 | $1K | |
| 85652 | <1% | 349 | $935.30 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,656 | $867.50 |
| 83735 | <1% | 5,181 | $841.48 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,421 | $832.38 |
| 86762 | <1% | 221 | $775.78 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 499 | $633.53 |
| 80050 | General health panel | <1% | 15 | $630.72 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 14 | $627.86 |
| 83540 | <1% | 306 | $607.80 | |
| 86787 | <1% | 260 | $584.23 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 14 | $570.07 |
| 87140 | <1% | 1,299 | $517.49 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,778 | $512.54 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,145 | $433.55 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 158 | $421.22 |
| 94760 | <1% | 123 | $329.85 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 448 | $329.85 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 197 | $296.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,556 | $276.84 |
| 82550 | <1% | 818 | $256.70 | |
| 82043 | <1% | 95 | $250.61 | |
| G0659 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | <1% | 361 | $192.26 |
| 87340 | <1% | 623 | $178.32 | |
| 80143 | <1% | 28 | $152.83 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 941 | $132.75 |
| 96376 | <1% | 190 | $32.60 | |
| 90715 | <1% | 297 | $28.27 | |
| 87186 | <1% | 2,779 | $28.02 | |
| 85660 | <1% | 221 | $20.35 | |
| 86901 | <1% | 1,299 | $11.26 | |
| 85730 | <1% | 2,266 | $10.95 | |
| 82553 | <1% | 571 | $6.75 | |
| 84132 | <1% | 13 | $3.41 | |
| 85014 | <1% | 20 | $2.12 | |
| 87205 | <1% | 189 | $2.10 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 280 | $1.23 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,999 | $0.48 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 136 | $0.24 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,199 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 846 | $0.00 |
| J3490 | Unclassified drugs | 0% | 3,331 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 1,240 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 1,542 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 310 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 165 | $0.00 |
| 82150 | 0% | 347 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 261 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 143 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 314 | $0.00 |
| 85018 | 0% | 46 | $0.00 | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 0% | 12 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 75 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 37 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 12 | $0.00 |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 0% | 86 | $0.00 |
| 86706 | 0% | 64 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 68 | $0.00 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 13 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 17 | $0.00 |
| 74021 | 0% | 15 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 127 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 134 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 2,866 | $0.00 |
| 80179 | 0% | 26 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 322 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 271 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 201 | $0.00 |
| 84466 | 0% | 45 | $0.00 | |
| 84100 | 0% | 53 | $0.00 | |
| 85045 | 0% | 12 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 13 | $0.00 |
| 82397 | 0% | 16 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 18 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEINKE, KENNETH (CHIEF FINANCIAL OFFICER)
Parent organizationSPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC.
| Provider | Location | Paid |
|---|---|---|
| Spartanburg Medical Center | Spartanburg, SC | $187.76M |
| Pelham Medical Center | Greer, SC | $13.82M |
| Spartanburg Medical Center | Spartanburg, SC | $11.52M |
| Spartanburg Medical Center | Drayton, SC | $8.86M |
| Spartanburg Medical Center | Spartanburg, SC | $4.17M |
| Spartanburg Medical Center | Spartanburg, SC | $3.72M |
| Spartanburg Medical Center | Spartanburg, SC | $1.94M |
| Spartanburg Medical Center | Boiling Springs, SC | $1.92M |
| Spartanburg Medical Center | Spartanburg, SC | $1.39M |
| Spartanburg Medical Center | Spartanburg, SC | $990K |
| Spartanburg Medical Center | Greenville, SC | $943K |
| Spartanburg Medical Center | Spartanburg, SC | $911K |
| Spartanburg Medical Center | Gaffney, SC | $785K |
| Spartanburg Medical Center | Spartanburg, SC | $726K |
| Spartanburg Medical Center | Spartanburg, SC | $680K |
| Spartanburg Medical Center | Inman, SC | $669K |
| Spartanburg Medical Center | Pacolet, SC | $462K |
| Spartanburg Medical Center | Landrum, SC | $446K |
| Spartanburg Medical Center | Spartanburg, SC | $413K |
| Spartanburg Medical Center | Spartanburg, SC | $325K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.